Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02618915
What this trial is testing

Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Early research (Phase 1)Study completedNCT06025552
What this trial is testing

Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects

Who this might be right for
Hemophilia aHemophilia BBlood Coagulation Disorders
TiumBio Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT01496274
What this trial is testing

A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 63
Large-scale testing (Phase 3)Study completedNCT03974113
What this trial is testing

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 32
Not applicableStudy completedNCT01589848
What this trial is testing

Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador

Who this might be right for
Von Willebrand DiseaseHemophilia AHemophilia B
Universidad del Azuay 81
Testing effectiveness (Phase 2)Study completedNCT06289166
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 25
Not applicableLooking for participantsNCT06820515
What this trial is testing

ATHNdataset Registry

Who this might be right for
HemophiliaThrombosisHemophilia A+6 more
American Thrombosis and Hemostasis Network 200,000
Not applicableStudy completedNCT05879549
What this trial is testing

Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With Hemophilia

Who this might be right for
Hemophilia AHemophilia B
Bahçeşehir University 46
Large-scale testing (Phase 3)Looking for participantsNCT06700096
What this trial is testing

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Who this might be right for
Hemophilia B
Biocad 24
Very early researchStudy completedNCT05281718
What this trial is testing

Factor IX as Adjunctive Therapy to Emicizumab (EMIX)

Who this might be right for
Hemophilia A
Tulane University 12
Not applicableStudy completedNCT02049099
What this trial is testing

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

Who this might be right for
Haemophilia AHaemophilia B
Swedish Orphan Biovitrum 1,658
Testing effectiveness (Phase 2)Looking for participantsNCT07644832
What this trial is testing

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Who this might be right for
Hemophilia AHemophilia BFactor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd. 76
Large-scale testing (Phase 3)Study completedNCT00364182
What this trial is testing

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 50
Not applicableStudy completedNCT07101224
What this trial is testing

Data Registry in Chinese Hemophilia A and B Patients

Who this might be right for
Hemophilia AHemophilia B
Institute of Hematology & Blood Diseases Hospital, China 200
Not applicableStudy completedNCT02199717
What this trial is testing

An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia

Who this might be right for
Hemophilia AHemophilia BFactor VIII Deficiency+1 more
The Hospital for Sick Children 66
Not applicableStudy completedNCT01220141
What this trial is testing

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 51
Not applicableLooking for participantsNCT05630651
What this trial is testing

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 6
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Not applicableStudy completedNCT00167973
What this trial is testing

Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 218
Large-scale testing (Phase 3)Study completedNCT03549871
What this trial is testing

Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 80
Next Page